Advanced Cell Technology announces clinical milestone Advanced Cell Technology announced that investigators for the Company's Phase I/II clinical trials for Stargardt's macular dystrophy, or SMD, and dry age-related macular degeneration have observed evidence of engraftment of the transplanted human embryonic stem cell, or hESC,-derived retinal ... (more)
http://www.theflyonthewall.com/permalinks/entry.php/ACTCid1764684/ACTC-Advanced-Cell-Technology-announces-clinical-milestone
http://www.theflyonthewall.com/permalinks/entry.php/ACTCid1764684/ACTC-Advanced-Cell-Technology-announces-clinical-milestone
No comments:
Post a Comment